Psoriatic leukotactic factor. Further physicochemical characterization and effect on the epidermal cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of Dermatological Research

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/BF00509048PMID 7165329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The human epidermal cells infected with herpes simplex virus in vitro

  2004cited by this paper
• Abnormalities in the alternative pathway of complement in psoriasis

  1982cited by this paper
• Isolation and characterization of an acidic chemotactic factor from complement-activated human serum.

  1980influential reference
• Deposits of Immunoglobulin and Complement in Psoriatic Lesions

  1980cited by this paper
• The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis.

  1980cited by this paper
• Analysis of immunological responses in psoriatic lesions: (1) immunopathological studies on psoriatic lesions.

  1980cited by this paper
• Alteration of HeLa cell growth equilibrium by supernatants of peripheral blood mononuclear cells from normal and psoriatic subjects.

  1980cited by this paper
• Cell proliferation in psoriatics.

  1979cited by this paper
• Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo.

  1979cited by this paper
• A leukotactic factor in the stratum corneum of pustulosis palmaris et plantaris: a possible mechanism for the formation of intra-epidermal sterile pustules.

  1978cited by this paper
• Chemokinetic and chemotactic factors in psoriasis scale extracts.

  1978cited by this paper
• DNA synthesis among uninvolved and involved psoriatic epidermal cells and normal epidermal cells in vitro.

  1978cited by this paper
• Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

  1978cited by this paper
• Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris.

  1978cited by this paper
• Characterization of a leukotactic factor derived from psoriatic scale

  1977influential reference
• [Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test].

  1977cited by this paper
• Demonstration of C3 cleavage product in leukotactic substances of scale extract from pustular psoriasis

  1977cited by this paper
• Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.

  1977cited by this paper
• Leukotactic properties of soluble substances inpsoriasis scale

  1976influential reference
• Studies in immunodermatology. VI. IF studies of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic lesions.

  1975cited by this paper
• Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.

  1975cited by this paper
• Antibodies in Psoriatic Scales

  1973influential reference
• Tritiated thymidine labelling of epidermis in pustular psoriasis.

  1972cited by this paper
• Tritiated Thymidine Labelling of Epidermis in Pustular Psoriasis

  1972cited by this paper
• Histological variations in lesions of psoriasis.

  1972cited by this paper
• Cell cycle of normal and psoriatic epidermis in vitro.

  1972cited by this paper
• Patterns and sequence of tissue changes in incipient and evolving lesions of psoriasis.

  1972cited by this paper
• The behavior of explants of psoriasis in vitro.

  1969cited by this paper
• [Leukotactic properties of psoriasis scales].

  1966cited by this paper
• The primary histologic lesion of seborrheic dermatitis and psoriasis.

  1966cited by this paper

• Complement Activation in Inflammatory Skin Diseases

  2018cites this paper
• Noninvasive proteome analysis of psoriatic stratum corneum reflects pathophysiological pathways and is useful for drug profiling

  2017cites this paper
• Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales

  2005cites this paper
• Leukocyte chemotactic properties of soluble horny contents in epidermal cysts

  2004cites this paper
• Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method

  2004cites this paper
• Demonstration of neutrophil chemotactic anaphylatoxins in human dandruff

  2004influential citation
• Identification of Diacylated Ureas as a Novel Family of Fungus-specific Leukocyte-activating Pathogen-associated Molecules*

  2002cites this paper
• Chemoattractants as mediators of neutrophilic tissue recruitment.

  2000cites this paper
• Pustular psoriasis and aseptic purulent arthritis: possible role of leukotrienes B4 and C4 in a flare of synovitis.

  1995cites this paper
• Inflammatory mediators and chemoattractants.

  1995cites this paper
• Interleukin 8: Roles in psoriasis.

  1995cites this paper
• The pustule in palmoplantar psoriasis: transformed vesicle or mature microabscess? A three-dimensional study.

  1992cites this paper
• Biochemical and biological characterization of NAP-1/IL-8-related cytokines in lesional psoriatic scale.

  1991cites this paper
• Leukocyte chemoattractant cytokines of the epidermis.

  1990cites this paper
• Formation of sterile pustule. The role of an interaction between corneocytes and neutrophils.

  1990cites this paper
• Identification of a group of proteins that are strongly up‐regulated in total epidermal keratinocytes from psoriatic skin

  1990cites this paper
• A two‐dimensional gel protein database of noncultured total normal human epidermal keratinocytes: Identification of proteins strongly up‐regulated in psoriatic epidermis

  1990cites this paper
• Monocyte and neutrophil chemotaxis in psoriasis. Clinical and experimental studies.

  1989cites this paper
• Polypeptide neutrophil chemoattractants in the skin.

  1989cites this paper
• Cutaneous pharmacology: perspectives on the growth of investigation of mediators of inflammation.

  1989cites this paper
• Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.

  1989cites this paper
• Effects of psoriatic scale extracts on oxidative metabolic responses in granulocytes assessed by chemiluminescence

  1989cites this paper
• Low‐molecular‐weight Leukocyte Chemotactic Factors in Psoriatic Scales: Contribution of Lipid‐soluble Factors to the Chemotactic Activity

  1988cites this paper
• Electrophoretic Mobility of Polymorphonuclear Leukocytes Response to Scale Extracts from Psoriasis Vulgaris

  1988cites this paper
• Interleukin-1. A new mediator in dermatology.

  1987cites this paper
• Treatment of subcorneal pustulosis by etretinate.

  1987cites this paper
• Production of a chemotactic factor for polymorphonuclear leukocytes by epithelioid cells from rat renal glomeruli in culture.

  1987cites this paper
• Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis.

  1987cites this paper
• Inflammatory mediators in the skin.

  1987cites this paper
• Aberrant expression of a chemokinetic glycoprotein in psoriatic skin.

  1987cites this paper
• The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.

  1987cites this paper
• Effect of UV irradiation on expression of membrane IL 1 by rat macrophages.

  1987cites this paper
• Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound.

  1986cites this paper
• Interleukin-1-like activity in horny layer extracts: decreased activity in scale extracts of psoriasis and sterile pustular dermatoses.

  1986cites this paper
• Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.

  1986cites this paper
• Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.

  1986cites this paper
• Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses

  1986cites this paper
• Beta-glucuronidase of neutrophils in psoriasis.

  1986cites this paper
• Epidermal interleukin 1: from an in vitro phenomenon to a (patho-)physiological role?

  1986cites this paper
• The role of chemo‐attractant lipoxygenase products in the pathogenesis of psoriasis

  1985cites this paper
• Arachidonate Lipoxygenase Products and Psoriasis

  1985cites this paper
• Eosinophilic pustular folliculitis. Report of two cases with a review of the Japanese literature.

  1985cites this paper
• Increased anaphylatoxins (C3a and C4a) in psoriatic sera

  1985cites this paper
• Pustulosis vegetans.

  1984cites this paper
• The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.

  1984cites this paper
• Possible relevance to dermatology of epidermal cell thymocyte-activating factor (ETAF).

  1983cites this paper
• Subcorneal pustular dermatosis with vesiculo‐bullous eruption. Demonstration of subcorneal IgA deposits and a leukocyte chemotactic factor

  1983cites this paper
• Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.

  1983cites this paper